Adicet Bio
ACET
#9448
Rank
A$0.12 B
Marketcap
A$0.81
Share price
-3.75%
Change (1 day)
-47.32%
Change (1 year)

Operating Margin for Adicet Bio (ACET)

Operating Margin as of December 2025 (TTM): -279.27%

According to Adicet Bio's latest financial reports and stock price the company's current Operating Margin is -279.27%. At the end of 2022 the company had an Operating Margin of -279.27%.

Operating Margin history for Adicet Bio from 2020 to 2022

Operating Margin at the end of each year

Year Operating Margin Change
2022-279.27%-56.26%
2021-638.48%189.44%
2020-220.59%-92.19%
2019-2,826.03%2238.16%
2018-120.87%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Quaker Houghton
KWR
8.42%-103.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
31.06%-111.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
12.60%-104.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
-7.76%-97.22%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
29.12%-110.43%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Hawkins
HWKN
10.76%-103.85%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.